Zenas BioPharma (ZBIO) Tax Provisions (2025)

Zenas BioPharma (ZBIO) recorded quarterly Tax Provisions of $106000.0 in Q4 2025, up 430.0% quarter-over-quarter from $20000.0 in Q2 2025.

Zenas BioPharma (ZBIO) Tax Provisions (2025) Analysis & Trends

Zenas BioPharma's Tax Provisions history runs 1 years deep, the most recent figure standing at $106000.0 for Q4 2025.

In Q4 2025, Tax Provisions changed N/A year-over-year to $106000.0; the TTM figure through Dec 2025 stood at -$79000.0 (changed N/A YoY), while the FY2025 annual figure was -$79000.0, down 118.41% from the prior year.
Tax Provisions was $106000.0 for Q4 2025 at Zenas BioPharma, up from $20000.0 in the prior quarter.
In the past five years, Tax Provisions ranged from a high of $106000.0 in Q4 2025 to a low of -$205000.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-11.20 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	216,000.00
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-859,000.00
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	221.50 Mn
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Zenas BioPharma	1.10 Bn	379.43 Mn	-	-

Download Data